June 9, 2026
City Therapeutics
City Therapeutics closed a $99.5 million Series B to push two RNAi programs into the clinic this year.
- Round
- Series B
- Amount raised
- $99.5M
- Lead investor
- —
- Industry
- Biotechnology
- Headquarters
- United States
- Employees
- 11-50 employees
- Website
- —
- View profile →
Source: The Pharma Letter